咽鼓管球囊扩张术联合鼓膜置管术治疗慢性分泌性中耳炎疗效分析  

Treatment outcomes of medication therapy and balloon eustachian tuboplasty plus tympanostomy tube insertion for chronic secretory otitis media

作　　者：葛亮 朱顺芳 GE Liang;ZHU Shunfang(Department of Otolaryngology-Head and Neck Surgery,The First Affiliated Hospital of Wannan Medical College,Wuhu 241001,Anhui,China)

机构地区：[1]皖南医学院第一附属医院弋矶山医院耳鼻咽喉头颈外科,安徽芜湖241001

出　　处：《皖南医学院学报》2024年第3期226-228,233,共4页Journal of Wannan Medical College

基　　金：皖南医学院重点项目科研基金(WK2023ZZD29)。

摘　　要：目的:分析药物治疗和咽鼓管球囊扩张术联合鼓膜置管术治疗慢性分泌性中耳炎临床疗效。方法:选取2019年11月~2023年3月弋矶山医院60例慢性分泌性中耳炎患者进行分组,观察组30例接受咽鼓管球囊扩张术+鼓膜置管术,对照组30例采用药物治疗,记录两组患者的纯音听阈均值(PTA)、气骨导差(ABG)以及咽鼓管功能障碍7项评分问卷(ETDQ-7)评分。结果:观察组术后总体有效率(100.00%)高于对照组(70.00%)(P<0.01)。观察组患者治疗前、治疗后1个月及治疗后3个月的PTA、ABG、ETDQ-7评分均较对照组患者下降(P<0.05)。结论:咽鼓管球囊扩张术联合鼓膜置管术治疗慢性分泌性中耳炎安全有效,值得临床推广应用。Objective:To compare the clinical efficacy of medication therapy and balloon eustachian tuboplasty plus tympanostomy tube insertion for chronic secretory otitis media.Methods:Sixty patients with chronic secretory otitis media treated in our hospital were included between November 2019 and March 2023 and divided into observational group and control group,in which patients received balloon eustachian tuboplasty(BET)plus tympanostomy tube insertion(TTI)and medication therapy respectively(both n=30).The pure tone audiometry(PTA),air-bone gap(ABG),and 7-item Eustachian Tube Dysfunction Questionnaire(ETDQ-7)scores were recorded in both groups.Results:The overall effective rate in the observational group was higher than that in the control group(100.00%vs.70.00%,P<0.01).The PTA,ABG and ETDQ-7 scores in both groups decreased sequentially before treatment,at 1 and 3 months after treatment(P<0.05).Conclusion:The clinical efficacy of BET plus TTI is favorable in the treatment of chronic secretory otitis media and it is worthy of clinical recommendation.

关 键 词：咽鼓管球囊扩张术 鼓膜置管 纯音听阈 慢性分泌性中耳炎 

分 类 号：R764.21[医药卫生—耳鼻咽喉科]